Search Results - "Zawada, James"
-
1
Microscale to manufacturing scale-up of cell-free cytokine production-a new approach for shortening protein production development timelines
Published in Biotechnology and bioengineering (01-07-2011)“…Engineering robust protein production and purification of correctly folded biotherapeutic proteins in cell‐based systems is often challenging due to the…”
Get full text
Journal Article -
2
Cell-free technologies for biopharmaceutical research and production
Published in Current opinion in biotechnology (01-08-2022)“…Cell-free protein synthesis (CFPS) technologies have grown from lab-scale research tools to biopharmaceutical production at the Good Manufacturing Practice…”
Get full text
Journal Article -
3
A simplified and robust protocol for immunoglobulin expression in Escherichia coli cell-free protein synthesis systems
Published in Biotechnology progress (01-05-2015)“…Cell‐free protein synthesis (CFPS) systems allow for robust protein expression with easy manipulation of conditions to improve protein yield and folding…”
Get full text
Journal Article -
4
Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system
Published in mAbs (01-03-2012)“…We describe protein synthesis, folding and assembly of antibody fragments and full-length aglycosylated antibodies using an Escherichia coli-based open…”
Get full text
Journal Article -
5
An Integrated In Vivo/In Vitro Protein Production Platform for Site-Specific Antibody Drug Conjugates
Published in Bioengineering (Basel) (28-02-2023)“…The XpressCF+ cell-free protein synthesis system is a robust platform for the production of non-natural amino acids containing antibodies, which enable the…”
Get full text
Journal Article -
6
Streamlining Escherichia Coli S30 Extract Preparation for Economical Cell-Free Protein Synthesis
Published in Biotechnology progress (01-03-2005)“…Escherichia coli extracts activate cell‐free protein synthesis systems by providing the catalysts for translation and other supporting reactions. Recent…”
Get full text
Journal Article -
7
Maintaining rapid growth in moderate-density Escherichia coli fermentations
Published in Biotechnology and bioengineering (20-02-2005)“…A novel feeding strategy that prolongs rapid growth rates for Escherichia coli fermentations to moderately high cell density is presented. High‐density…”
Get full text
Journal Article -
8
Effects of growth rate on cell extract performance in cell-free protein synthesis
Published in Biotechnology and bioengineering (05-07-2006)“…Cell‐free protein synthesis is a useful research tool and now stands poised to compete with in vivo expression for commercial production of proteins. However,…”
Get full text
Journal Article -
9
Preparation and testing of E. coli S30 in vitro transcription translation extracts
Published in Methods in molecular biology (Clifton, N.J.) (2012)“…Crude cell-free extracts are useful tools for investigating biochemical phenomena and exploiting complex enzymatic processes such as protein synthesis…”
Get more information
Journal Article -
10
Abstract 742: Nonclinical safety evaluation of STRO-001, a site-specific anti-CD74 antibody-drug conjugate for the potential treatment of B-cell malignancies
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Antibody-drug conjugates (ADCs) constitute an expanding class of therapeutic molecules in preclinical and clinical development for multiple oncology…”
Get full text
Journal Article -
11
Abstract NT-090: PRECLINICAL ACTIVITY AND SAFETY OF STRO-002, A NOVEL ADC TARGETING FOLATE RECEPTOR ALPHA FOR OVARIAN AND ENDOMETRIAL CANCER
Published in Clinical cancer research (15-11-2019)“…Abstract OBJECTIVES: Folate receptor alpha (FolRα) is a cell-surface glycoprotein, highly expressed in ovarian and endometrial adenocarcinoma, and thus a…”
Get full text
Journal Article -
12
Abstract 67: Characterization and preclinical development of STRO-001, a novel CD74-targeting antibody-drug conjugate (ADC) for the treatment of B-cell malignancies
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract CD74 is a type II transmembrane glycoprotein involved in the formation and transport of MHC class II protein. CD74 is highly expressed in many B-cell…”
Get full text
Journal Article -
13
Abstract 1782: Discovery and activity of STRO-002, a novel ADC targeting folate receptor alpha for ovarian and endometrial cancer
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Folate receptor alpha (FolRα) is a glycosylphosphatidylinositol linked cell-surface glycoprotein that is widely expressed in serous and epithelial…”
Get full text
Journal Article -
14
Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL)
Published in Blood (02-12-2016)“…CD74 is a type II transmembrane glycoprotein involved in the formation and transport of MHC class II protein. High expression of CD74 has been confirmed in…”
Get full text
Journal Article -
15
Discovery and Preclinical Development of Novel CD74-Targeting Antibody-Drug Conjugates (ADCs) with Significant Activity in Multiple Myeloma (MM) Cell Lines and Xenograft Models
Published in Blood (02-12-2016)“…CD74, also known as HLA-DR-associated invariant chain, is a type II transmembrane glycoprotein highly expressed in many B-cell malignancies. The limited…”
Get full text
Journal Article -
16
A simplified and robust protocol for immunoglobulin expression in E scherichia coli cell‐free protein synthesis systems
Published in Biotechnology progress (01-05-2015)“…Cell‐free protein synthesis (CFPS) systems allow for robust protein expression with easy manipulation of conditions to improve protein yield and folding…”
Get full text
Journal Article -
17
Scale-up, optimization, and analysis of Escherichia coli extracts for cell -free protein synthesis
Published 01-01-2004“…Cell-free protein synthesis systems have been used for decades to study transcription and translation, and they continue to be used to produce proteins for…”
Get full text
Dissertation